APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-37917 | Pharmaceuticals and Medical
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Application of BCG vaccine in the prevention of COVID-19 Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET
7.1 GLOBAL APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA APPLICATION OF BCG VACCINE IN THE PREVENTION OF COVID-19 MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Japan BCG Lab
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 InterVax
16.3 Merck
16.4 GreenSignal
16.5 Shanyao Group
16.6 Sanofi Pasteur
16.7 China National Biotec
16.8 Statens Serum Institute
16.9 Serum Institute of India
16.10 Shanghai Institute of Biological Products
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types Covered2ml each
1ml each
05 ml each
other
Major Downstream Industry Covered
5-18 years old
18-45 years old
0-5 years old
45 to 65 years old
65 years old and above
Companies
Japan BCG Lab
InterVax
Merck
GreenSignal
Shanyao Group
Sanofi Pasteur
China National Biotec
Statens Serum Institute
Serum Institute of India
Shanghai Institute of Biological Products
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.